Articles published by Denali Therapeutics Inc.![]()
Denali Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
February 27, 2023
Via Globe NewsWire
Tickers
DNLI
![]() ![]() ![]() ![]() ![]()
Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform Trial
December 05, 2022
Via Globe NewsWire
Tickers
DNLI
![]()
Denali Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
November 03, 2022
Via Globe NewsWire
Tickers
DNLI
![]() ![]() ![]()
Denali Therapeutics Announces Pricing of $275 Million Public Offering of Common Stock
October 19, 2022
Via Globe NewsWire
Tickers
DNLI
![]()
Denali Therapeutics Announces Proposed Offering of Common Stock
October 18, 2022
Via Globe NewsWire
Tickers
DNLI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|